LATE-BREAKING ABSTRACT: An electronic nose distinguishes the exhaled breath of patients with pleural malignant mesothelioma from subjects with professional asbestos exposure
S. D. Dragonieri, P. C. Carratu, A. P. Pinca, N. S. Schiavulli, D. C. Cavone, M. T. Tutino, G. D. Degennaro, A. S. Spanevello, O. R. Resta, P. S. Sterk, M. M. Musti (Cassano delle Murge, Bari, Tradate, Italy; Amsterdam, Netherlands)
Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. D. Dragonieri, P. C. Carratu, A. P. Pinca, N. S. Schiavulli, D. C. Cavone, M. T. Tutino, G. D. Degennaro, A. S. Spanevello, O. R. Resta, P. S. Sterk, M. M. Musti (Cassano delle Murge, Bari, Tradate, Italy; Amsterdam, Netherlands). LATE-BREAKING ABSTRACT: An electronic nose distinguishes the exhaled breath of patients with pleural malignant mesothelioma from subjects with professional asbestos exposure. Eur Respir J 2009; 34: Suppl. 53, 3224
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Chemical characterization of exhaled breath to discriminate patients with malignant pleural mesothelioma from subjects with similar professional asbestos exposure Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010
Exhaled breath analysis allows exclusive screening for malignant pleural mesothelioma. Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Exhaled breath to screen for malignant pleural mesothelioma: a validation study Source: Eur Respir J, 50 (6) 1700919; 10.1183/13993003.00919-2017 Year: 2017
A breath test for malignant mesothelioma using an electronic nose Source: Eur Respir J 2012; 40: 448-454 Year: 2012
Pleural neoplasms – linkage with professional asbestos exposure Source: Eur Respir J 2006; 28: Suppl. 50, 702s Year: 2006
An electronic nose distinguishes the exhaled breath condensates of AATD patients and healthy controls Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs Year: 2008
Lung function in patients with benign asbestos related pleural disease Source: Eur Respir J 2003; 22: Suppl. 45, 185s Year: 2003
Drug repurposing in malignant pleural mesothelioma: a breath of fresh air? Source: Eur Respir Rev, 27 (147) 170098; 10.1183/16000617.0098-2017 Year: 2018
Proportion of patients with malignant pleural mesothelioma whose asbestos body numbers in the lung are equal to general population Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
BAL and exhaled breath condensate in children: Is there any relationship between these fluids? Source: Eur Respir J 2003; 22: Suppl. 45, 399s Year: 2003
An electronic nose distinguishes the exhaled breath condensates of patient groups with COPD, alpha-1-antitrypsin deficiency and healthy controls Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006
The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Electronic nose versus exhaled no and bronchial challenge testing in asthma Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function? Year: 2009
Breath analysis allows to predict treatment response in malignant pleural mesothelioma patients. Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease Year: 2021
Different cytological alterations of bronchial mucosa in 178 smoking and non-smoking patients, suffering from COPD: the importance of endobronchial brushing Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung Year: 2009
The relationships between markers of inflammation in exhaled breath condensate and bronchoalveolar lavage in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 307s Year: 2004
The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016
Early detection of patients with asthma or chronic bronchitis by investigation on exhaled air condensate Source: Eur Respir J 2002; 20: Suppl. 38, 275s Year: 2002
Association of exhaled breath condensate pH with markers of neutrophilic inflammation in bronchoalveolar lavage in young children with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010